THE ROLE OF INSULIN RESISTANCE IN THE PATHOGENESIS OF ISCHEMIC STROKE
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Main Article Content
Abstract:
Ischemic stroke remains a leading cause of mortality and long-term disability worldwide, despite advances in acute interventions and risk factor management. Insulin resistance (IR) — traditionally associated with type 2 diabetes mellitus — has emerged as an independent, modifiable risk factor for ischemic stroke. Beyond its metabolic implications, IR promotes endothelial dysfunction, accelerates atherosclerosis, enhances thrombogenesis, and exacerbates neuroinflammatory and oxidative processes, thereby influencing both stroke incidence and prognosis. This review synthesizes current evidence on the role of IR in ischemic stroke pathogenesis, integrating epidemiological data, molecular mechanisms, and potential clinical applications. Literature from PubMed, Scopus, and Web of Science (2010–2025) was analyzed, prioritizing cohort studies, randomized trials, and mechanistic research.
Article Details
How to Cite:
References:
Rundek et al. (2010, Alexander, M. R., Murgas, C. J., & Lee, K. L. (2021). Endothelial dysfunction and vascular inflammation in insulin resistance. Cardiovascular Research, 117(2), 271–285.
Maciejczyk M, Żebrowska E, Chabowski A. Insulin Resistance and Oxidative Stress in the Brain: What's New? Int J Mol Sci.
Billinger, S. A., Arena, R., Bernhardt, J., Eng, J. J., Franklin, B. A., Johnson, C. M., MacKay-Lyons, M., Macko, R. F., Mead, G. E., Roth, E. J., Shaughnessy, M., Tang, A., & American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, & Council on Clinical Cardiology. (2014). Physical activity and exercise recommendations for stroke survivors. Stroke, 45(8), 2532–2553.
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016). Neuroprotection in acute stroke: Targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. The Lancet Neurology, 15(8), 869–881. https://doi.org/10.1016/S1474-4422(16)00114-9
Chang Y, Kim CK, Kim MK, Seo WK, Oh K. Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients. Sci Rep. 2021 Jan 13;11(1):1229. doi: 10.1038/s41598-020-80315-z.
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., Simonson, D. C., Testa, M. A., Weiss, R., & Weiss, R. (2021). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 7(1), 41. https://doi.org/10.1038/s41572-021-00263-0
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., Lamuela-Raventós, R. M., Serra-Majem, L., Pintó, X., Basora, J., Muñoz, M. A., Sorlí, J. V., Martínez, J. A., Fitó, M., Gea, A., ... Martínez-González, M. A. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. The New England Journal of Medicine, 368(14), 1279–1290. https://doi.org/10.1056/NEJMoa1200303
Feng, B., Zhang, C., Liu, Y., Xu, Y., Wu, Y., & Li, X. (2020). MicroRNA-223 regulates platelet activation and thrombus formation. Blood, 136(23), 2624–2635. https://doi.org/10.1182/blood.2020005767
You, Cheng-jin MMa,b; Liu, Dan MMa; Liu, Li-li MMa; Li, Guo-zhong PhDa,*. Correlation between acute stroke-induced white matter lesions and insulin resistance. Medicine 97(11):p e9860, March 2018. | DOI: 10.1097/MD.0000000000009860
Zhou M, Zhou Y, Jing J, Wang M, Jin A, Cai X, Meng X, Liu T, Wang Y, Wang Y, Pan Y. Insulin resistance and white matter microstructural abnormalities in nondiabetic adult: A population-based study. Int J Stroke. 2024 Dec;19(10):1162-1171. doi: 10.1177/17474930241266796.
Jin A, Wang S, Li J, Wang M, Lin J, Li H, Meng X, Wang Y, Pan Y. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke. Stroke. 2023 Mar;54(3):759-769. doi: 10.1161/STROKEAHA.122.039542.
Katsumata T, Otori T, Nishiyama Y, Okubo S, Nishiyama Y, Nagayama H, Ueda M, Utsumi K, Yamazaki M, Komaba Y, Katsura K, Katayama Y. Correlation between insulin resistance and white matter lesions among non-diabetic patients with ischemic stroke. Neurol Res. 2010 Sep;32(7):743-7. doi: 10.1179/016164109X12608733393755.
Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, McVeety JC, Horwitz RI. Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology. 2003 May 13;60(9):1447-51. doi: 10.1212/01.wnl.0000063318.66140.a3.
Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Häring HU. Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. Physiol Rev. 2016 Oct;96(4):1169-209. doi: 10.1152/physrev.00032.2015
Li, Y., Chen, X., Li, L., & Zhang, Y. (2021). Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients. BMC Neurology, 21, 126. https://doi.org/10.1186/s12883-021-02192-1
Look AHEAD Research Group. (2014). Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study. Obesity, 22(1), 5–13. https://doi.org/10.1002/oby.20662
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., Steinberg, W. M., Stockner, M., Zinman, B., ... LEADER Steering Committee and Investigators. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. The New England Journal of Medicine, 375(4), 311–322. https://doi.org/10.1056/NEJMoa1603827
Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord. 2013 Mar;14(1):5-12. doi: 10.1007/s11154-012-9229-1. PMID: 23306778; PMCID: PMC3594115.
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., Rochon, J., Gallup, D., Ilkayeva, O., Wenner, B. R., Yancy, W. S., Eisenson, H., Musante, G., Surwit, R. S., Millington, D. S., ... Svetkey, L. P. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism, 9(4), 311–326. https://doi.org/10.1016/j.cmet.2009.02.002
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nature Reviews Immunology, 11(2), 85–97. https://doi.org/10.1038/nri2921
Potenza MA, Gagliardi S, Nacci C, Carratu' MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009;16(1):94-112. doi: 10.2174/092986709787002853.
Rempe, R. G., Hartz, A. M. S., & Bauer, B. (2016). Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers. Journal of Cerebral Blood Flow & Metabolism, 36(9), 1481–1507. https://doi.org/10.1177/0271678X16655551
Rena, G., Hardie, D. G., & Pearson, E. R. (2017). The mechanisms of action of metformin. Diabetologia, 60(9), 1577–1585. https://doi.org/10.1007/s00125-017-4342-z
Rudovich, N. N., Pivovarova, O., & Pfeiffer, A. F. H. (2007). The role of insulin resistance in the pathogenesis of ischemic stroke. Diabetes/Metabolism Research and Reviews, 23(7), 507–514. https://doi.org/10.1002/dmrr.733
Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., Ruiz-Gutiérrez, V., Ros, E., & PREDIMED Study Investigators. (2018). Reduction in the incidence of type 2 diabetes with the Mediterranean diet: Results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care, 34(1), 14–19. https://doi.org/10.2337/dc10-1288Gastroenterology, 132(6),